The gut microbiome is at the center of inflammatory bowel disease (IBD) pathogenesis and
disease activity. While this has mainly been studied in the context of the bacterial …

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a
chronic intestinal inflammation of unknown etiology. The diagnosis of IBD is based on …

The diagnosis of inflammatory bowel disease (IBD) is traditionally based on a combination
of clinical, endoscopic, histological, and radiological criteria. However, further testing is …

Background and aims: Several antibodies have been reported in the sera of patients with
Crohn's disease (CD) and ulcerative colitis (UC). The most commonly described are anti …

Background & Aims: New serologic markers of inflammatory bowel disease may be useful
for differentiating between Crohn's disease and ulcerative colitis and for disease …

The gut microbiome has been implicated in the pathogenesis of inflammatory bowel disease
(IBD). Studies suggest that the IBD gut microbiome is less diverse than that of the unaffected …

Background & Aims: The cumulative incidence of surgery ranges from 40%–70% at 10 years
from the time of diagnosis of Crohn's disease in adults. We retrospectively determined the …

Objective Anti-neutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae
mannan antibodies (ASCAs) have been detected in the serum of patients with ulcerative …

Crohn's disease is characterized by inflammation that involves the full thickness of the bowel
wall, which can lead to serious complications including intra-abdominal and pelvic …

Sažetak Inflammatory bowel disease (IBD) is a heterogeneous group of chronic
inflammatory disorders of the gastrointestinal tract with two main distinguishable entities …